Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Clinicopathological characteristics of clinical samples and expression of C14orf166 in Human bladder cancer

From: C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation

Characteristics Number of cases (%)
Age (years)
 <64 81 (47.1)
 ≥64 91 (52.9)
Gender
 Male 156 (90.7)
 Female 16 (9.3)
T classification
 T1 91 (52.9)
 T2 81 (47.1)
N classification
 N0 150 (87.2)
 N1 22 (12.8)
Recurrence
 No 82 (47.7)
 Yes 90 (52.3)
Vital status (at follow-up)
 Alive 67 (39.0)
 Dead 105 (61.0)
Expression of C14orf166
 Low expression 87 (50.6)
 High expression 85 (49.4)
Number
 ≥3 64 (37.2)
 <3 108 (62.8)
Histological differentiation
 Well 32 (18.6)
 Moderate 54 (31.4)
 Poor 86 (50.0)
Tumor size
 ≥3 cm 100 (58.1)
 <3 cm 72 (41.9)